Sacroiliac Joint Fusion Market
Sacroiliac Joint Fusion Market Analysis by Indication (Degenerative Sacroiliitis, Sacral Disruption, Trauma), by Treatment Type (Sacroiliac Joint Fusion Surgery, Sacroiliac Joint Fusion Injections, RF Sacroiliac Joint Fusion Ablation), by End User & Regional Forecast 2022 to 2032
Analysis of Sacroiliac Joint Fusion market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Sacroiliac Joint Fusion Market Outlook (2022 to 2032)
The global sacroiliac joint fusion market size is estimated at US$ 620 Mn in 2022 and is likely to reach US$ 3,900 Mn by 2032. The market is expected to witness a CAGR of 20.2% during the forecast period from 2022 to 2032.
| Report Attributes | Details |
|---|---|
| Estimated Base Year Market Value (2021) | US$ 540 Mn |
| Anticipated Market Value in 2022 | US$ 620 Mn |
| Expected Forecast Market Value in 2032 | US$ 3,900 Mn |
| Global Growth Rate (2022 to 2032) | 20.2% CAGR |
| Market Share of North America | 42% |
| Expansion Rate of Asia Pacific | 17% CAGR |
| Key Companies Profiled | SI-BONE Inc.; PainTEQ; CornerLoc; SIGNUS Medizintechnik GmbH; Globus Medical; Orthofix Medical Inc.; Life Spine Inc.; Camber Spine Technologies LLC; CoreLink Surgical; Xtant Medical; Surgalign Spine Technologies Inc.; Medtronic Plc. |
The growth of the market can be attributed to the rapid technical development in the healthcare sector and the growing demand for minimally invasive surgical procedures.
Revenue Analysis of Global Sacroiliac Joint Fusion Market 2015 to 2021 vs. Future Outlook 2022 to 2032
The global sacroiliac joint market is likely to have secured a market value of US$ 540 Mn in 2021. The market growth can be acknowledged to the increasing adoption of technologies and new materials for offering safer joint fusions, which comprises the usage of 3D-printed titanium implants and additive manufacturing.
The sacroiliac joint fusion is likely to witness a significant rise in the coming time. The growth of the market is attributed to the increasing demand for its less invasive nature and lower costs. As per Fact. MR, the global sacroiliac joint fusion market is projected to secure a market value of US$ 3,900 Mn by 2032, while recording a CAGR of 20.2% during the timeframe of 2022 to 2032.
Why is Sacroiliac Joint Fusion Expected to Gain Traction during the Forecast Period?
Growing Demand for Minimally Invasive Surgeries to Fuel the Market
The increasing adoption of minimally invasive surgeries is anticipated to be the key factor driving the market during the forecast period. Further, the improving diagnostic capabilities for sacroiliac joint disorders and the adoption of new technologies are likely to offer better SI joint fusion systems.
In addition, the increasing geriatric population in developed countries like the US and the growing incidences of chronic diseases are anticipated to make a significant contribution in boosting the market. As per the 2019 data of the U.S Census Bureau, out of 328 million U.S population, about 75 Million were 60 years and above.
What is the Impact of COVID-19 on the Market?
The delayed elective surgeries hampered the market growth
The outbreak of COVID-19 resulted in reduced sales and low demand for the surgeries, thereby, hampering the market. The lockdown led to the postponement of elective surgeries and delayed clinical trials, taking the market graph down. The situation increased the need for innovation in healthcare facilities.
There was a tremendous rise in virtual medical services, however, various players faced losses. For instance, SI-BONE disclosed that its operations ran at low resources owing to the reduced demand for its iFuse product. The loss incurred by the company was due to the restrictions imposed on elective procedures owing to the pandemic.
Region-wise Analysis
How is North America Providing Growth Opportunities for Sacroiliac Joint Fusion?
Growing Prevalence of Joint Pains is Likely to Widen Revenue Prospects
According to estimates by Fact.MR, North America is expected to account for 42% revenue in 2022 and beyond. The large share of the region can be attributed to the presence of key players, advanced healthcare infrastructure, and growing reimbursement coverage. Moreover, an increased incidence of joint pain is also widening growth prospects.
The National Center for Biotechnology Information reports that annual prevalence of low back pain among adults ranges from 15% to 45% among adults in the U.S. In response to this burden of disease, and in the hopes of improving outcomes, significant efforts have been made to better understand the various etiologies of back pain. In particular, increasing attention has recently been given to the SI joint as a pain generator, and estimates of low back pain attributable to the SI joint range by 15% to 30%.
Will Asia Pacific Open Lucrative Growth Opportunities for Sacroiliac Joint Fusion?
Elevated Healthcare Spending to Ease the Burden of Joint Pains Bolstering Prospects
Asia Pacific is forecast to register an impressive growth rate across the 2022 to 2032 forecast period, registering a CAGR of 17%. This growth can be attributed to the presence of a large patient pool, developing healthcare facilities, and investments by key companies in this region.
High health care spending, rise in the number of minimally invasive procedures performed in the region, and high adoption of advanced technologies by the population are expected to boost sacroiliac fusion implants market growth in the Asia Pacific.
Category-wise Insights
Which Indication of Sacroiliac Joint Fusion is likely to dominate?
Joint Fusions for Degenerative Sacroiliitis Likely to Reign Supreme
By indication, Fact.MR expects the degenerative sacroiliitis segment to accumulate 39% of the market revenue in 2022 and beyond. High prevalence rates of degenerative sacroiliitis and the consequent improvement in improving diagnostic and treatment capabilities is driving demand.
At the same time, sacroiliac joint fusion for trauma injuries is expected to pick up considerable pace across the forecast period. The use of SI joint fusion systems in trauma indications is one the most recently approved indications by the FDA, thus contributing to the high growth rate of this segment.
For which Treatment Category will Sacroiliac Joint Fusion Gain Momentum?
Sacroiliac Joint Fusion for Surgeries to Accumulate Maximum Revenue Share
Sacroiliac joint fusion surgeries will likely account for 40% revenue in 2022. The increasing preference for minimally invasive surgeries due to the associated benefits, such as smaller incisions, reduced pain & scarring, and faster recovery times, is the major factor contributing to the high share of this segment.
As patients increasingly demand trauma-free surgeries, hospitals and other healthcare settings are emphasizing on including minimally invasive surgical alternatives, leading to reduced pain.
Competitive Landscape
Prominent sacroiliac joint fusion service providers are emphasizing on a host expansion strategies, ranging from product development, new product launches, collaborations and acquisitions. Moreover, several players are also involved in offering clinical testing of their products and patent applications. Some prominent developments are as follows:
- In September 2021, PainTEQ was granted 3 patents in the U.S. for its drill-less method of stabilizing an SI joint, abrading device used in the procedure, and allograft implant respectively. All three offerings are used in the company’s minimally invasive LinQ procedure for SI joint dysfunction, thus solidifying PainTEQ’s position in the market.
- In June 2020, Orthofix Medical Inc. launched FIREBIRD SI Fusion System through a limited market release in the U.S. The system uses a 3D-printed titanium bone screw that is implanted through a minimally invasive surgery for treating SI joint dysfunction.
Sacroiliac Joint Fusion Market Report Scope
| Attribute | Details |
|---|---|
| Historical Data Available For | 2015 to 2021 |
| Projected Forecast Period | 2022 to 2032 |
| Market Analysis | US$ Mn for Value and Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East & Africa |
| Key Segments Covered | Indication, Treatment Type, End User, Region |
| Key Countries Profiled | U.S, Canada, Brazil, Mexico, Germany, France, U.K, Italy, BENELUX, Nordics, China, Japan, South Korea, GCC, South Africa, Turkey |
Key Segments Covered in the Sacroiliac Joint Fusion Market Report
-
By Indication :
- Joint Fusion for Degenerative Sacroiliitis
- Joint Fusion for Sacral Disruption
- Sacroiliac Joint Fusion for Trauma
-
By Treatment Type :
- Sacroiliac Joint Fusion Surgery
- Surgery Type
- Minimally Invasive Sacroiliac Joint Fusion Surgery
- Open Sacroiliac Joint Fusion Surgery
- Approach
- Dorsal Sacroiliac Joint Fusion
- Anterior Sacroiliac Joint Fusion
- Product
- Sacroiliac Joint Fusion Implants
- Sacroiliac Joint Fusion Accessories
- Surgery Type
- Sacroiliac Joint Fusion Injections
- Diagnosis
- Treatment
- RF Sacroiliac Joint Fusion Ablation
- Sacroiliac Joint Fusion Surgery
-
By End User :
- Sacroiliac Joint Fusion in Hospitals
- Sacroiliac Joint Fusion in Ambulatory Surgical Centers
- Sacroiliac Joint Fusion for Other End Users (Specialty Centers and Research & Academic Institutes)
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background
- 5. Key Success Factors
- 6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032
- 7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032
- 8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Indication
- 8.1. Degenerative Sacroiliitis
- 8.2. Sacral Disruption
- 8.3. Trauma
- 9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Treatment Type
- 9.1. Surgery
- 9.1.1. By Surgery Type
- 9.1.1.1. MIS
- 9.1.1.2. Open
- 9.1.2. By Approach
- 9.1.2.1. Dorsal
- 9.1.2.2. Anterior
- 9.1.3. By Product
- 9.1.3.1. Implants
- 9.1.3.2. Accessories
- 9.1.1. By Surgery Type
- 9.2. Injections
- 9.3. Diagnosis
- 9.4. Treatment
- 9.5. RF Ablation
- 9.1. Surgery
- 10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By End User
- 10.1. Hospitals
- 10.2. Ambulatory Surgical Centers
- 10.3. Others (Specialty Centers, Research & Academic Institutes)
- 11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. Asia Pacific
- 11.5. Middle East and Africa (MEA)
- 12. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
- 13. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
- 14. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032
- 15. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032
- 16. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032
- 17. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032
- 18. Market Structure Analysis
- 19. Competition Analysis
- 19.1. SI-BONE, Inc.
- 19.2. PainTEQ
- 19.3. CornerLoc
- 19.4. SIGNUS Medizintechnik GmbH
- 19.5. Globus Medical
- 19.6. Orthofix Medical Inc.
- 19.7. Life Spine, Inc.
- 19.8. Camber Spine Technologies, LLC
- 19.9. CoreLink Surgical
- 19.10. Xtant Medical
- 19.11. Surgalign Spine Technologies, Inc.
- 19.12. Medtronic
- 20. Assumptions and Acronyms Used
- 21. Research Methodology
List Of Table
Table 1: Global Market Value (US$ Mn), By Indication, 2015 to 2021
Table 2: Global Market Value (US$ Mn), By Indication, 2022 to 2032
Table 3: Global Market Value (US$ Mn), By End User, 2015 to 2021
Table 4: Global Market Value (US$ Mn), By End User, 2022 to 2032
Table 5: Global Market Value (US$ Mn), By Treatment Type, 2015 to 2021
Table 6: Global Market Value (US$ Mn), By Treatment Type, 2022 to 2032
Table 7: Global Market, By Region, 2015 to 2021
Table 8: Global Market, By Region, 2022 to 2032
Table 9: North America Market Value (US$ Mn), By Indication, 2015 to 2021
Table 10: North America Market Value (US$ Mn), By Indication, 2022 to 2032
Table 11: North America Market Value (US$ Mn), By End User, 2015 to 2021
Table 12: North America Market Value (US$ Mn), By End User, 2022 to 2032
Table 13: North America Market Value (US$ Mn), By Treatment Type, 2015 to 2021
Table 14: North America Market Value (US$ Mn), By Treatment Type, 2022 to 2032
Table 15: North America Market, By Country, 2015 to 2021
Table 16: North America Market, By Country, 2022 to 2032
Table 17: Latin America Market Value (US$ Mn), By Indication, 2015 to 2021
Table 18: Latin America Market Value (US$ Mn), By Indication, 2022 to 2032
Table 19: Latin America Market Value (US$ Mn), By End User, 2015 to 2021
Table 20: Latin America Market Value (US$ Mn), By End User, 2022 to 2032
Table 21: Latin America Market Value (US$ Mn), By Treatment Type, 2015 to 2021
Table 22: Latin America Market Value (US$ Mn), By Treatment Type, 2022 to 2032
Table 23: Latin America Market, By Country, 2015 to 2021
Table 24: Latin America Market, By Country, 2022 to 2032
Table 25: Europe Market Value (US$ Mn), By Indication, 2015 to 2021
Table 26: Europe Market Value (US$ Mn), By Indication, 2022 to 2032
Table 27: Europe Market Value (US$ Mn), By End User, 2015 to 2021
Table 28: Europe Market Value (US$ Mn), By End User, 2022 to 2032
Table 29: Europe Market Value (US$ Mn), By Treatment Type, 2015 to 2021
Table 30: Europe Market Value (US$ Mn), By Treatment Type, 2022 to 2032
Table 31: Europe Market, By Country, 2015 to 2021
Table 32: Europe Market, By Country, 2022 to 2032
Table 33: Asia Pacific Market Value (US$ Mn), By Indication, 2015 to 2021
Table 34: Asia Pacific Market Value (US$ Mn), By Indication, 2022 to 2032
Table 35: Asia Pacific Market Value (US$ Mn), By End User, 2015 to 2021
Table 36: Asia Pacific Market Value (US$ Mn), By End User, 2022 to 2032
Table 37: Asia Pacific Market Value (US$ Mn), By Treatment Type, 2015 to 2021
Table 38: Asia Pacific Market Value (US$ Mn), By Treatment Type, 2022 to 2032
Table 39: Asia Pacific Market, By Country, 2015 to 2021
Table 40: Asia Pacific Market, By Country, 2022 to 2032
Table 41: MEA Market Value (US$ Mn), By Indication, 2015 to 2021
Table 42: MEA Market Value (US$ Mn), By Indication, 2022 to 2032
Table 43: MEA Market Value (US$ Mn), By End User, 2015 to 2021
Table 44: MEA Market Value (US$ Mn), By End User, 2022 to 2032
Table 45: MEA Market Value (US$ Mn), By Treatment Type, 2015 to 2021
Table 46: MEA Market Value (US$ Mn), By Treatment Type, 2022 to 2032
Table 47: MEA Market, By Country, 2015 to 2021
Table 48: MEA Market, By Country, 2022 to 2032
Table 49: Global Market Incremental $ Opportunity, By Indication, 2015 to 2021
Table 50: Global Market Incremental $ Opportunity, By End User, 2022 to 2032
Table 51: Global Market Incremental $ Opportunity, By Treatment Type, 2015 to 2021
Table 52: Global Market Incremental $ Opportunity, By Region, 2022 to 2032
Table 53: North America Market Incremental $ Opportunity, By Indication, 2015 to 2021
Table 54: North America Market Incremental $ Opportunity, By End User, 2022 to 2032
Table 55: North America Market Incremental $ Opportunity, By Treatment Type, 2015 to 2021
Table 56: North America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 57: Latin America Market Incremental $ Opportunity, By Indication, 2015 to 2021
Table 58: Latin America Market Incremental $ Opportunity, By End User, 2022 to 2032
Table 59: Latin America Market Incremental $ Opportunity, By Treatment Type, 2015 to 2021
Table 60: Latin America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 61: Europe Market Incremental $ Opportunity, By Indication, 2015 to 2021
Table 62: Europe Market Incremental $ Opportunity, By End User, 2022 to 2032
Table 63: Europe Market Incremental $ Opportunity, By Treatment Type, 2015 to 2021
Table 64: Europe Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 65: Asia Pacific Market Incremental $ Opportunity, By Indication, 2015 to 2021
Table 66: Asia Pacific Market Incremental $ Opportunity, By End User, 2022 to 2032
Table 67: Asia Pacific Market Incremental $ Opportunity, By Treatment Type, 2015 to 2021
Table 68: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 69: MEA Market Incremental $ Opportunity, By Indication, 2015 to 2021
Table 70: MEA Market Incremental $ Opportunity, By End User, 2022 to 2032
Table 71: MEA Market Incremental $ Opportunity, By Treatment Type, 2015 to 2021
Table 72: MEA Market Incremental $ Opportunity, By Country, 2022 to 2032
List Of Figures
Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 2: Global Market Absolute $ Historical Gain (2015 to 2021) and Opportunity (2022 to 2032), US$ Mn
Figure 3: Global Market Share, By Indication, 2022 & 2032
Figure 4: Global Market Y-o-Y Growth Projections, By Indication – 2022 to 2032
Figure 5: Global Market Attractiveness Index, By Indication – 2022 to 2032
Figure 6: Global Market Share, By End User, 2022 & 2032
Figure 7: Global Market Y-o-Y Growth Projections, By End User – 2022 to 2032
Figure 8: Global Market Attractiveness Index, By End User – 2022 to 2032
Figure 9: Global Market Share, By Treatment Type, 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Treatment Type – 2022 to 2032
Figure 11: Global Market Attractiveness Index, By Treatment Type – 2022 to 2032
Figure 12: Global Market Share, By Region, 2022 & 2032
Figure 13: Global Market Y-o-Y Growth Projections, By Region – 2022 to 2032
Figure 14: Global Market Attractiveness Index, By Region – 2022 to 2032
Figure 15: North America Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 16: North America Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 17: North America Market Share, By Indication, 2022 & 2032
Figure 18: North America Market Y-o-Y Growth Projections, By Indication – 2022 to 2032
Figure 19: North America Market Attractiveness Index, By Indication – 2022 to 2032
Figure 20: North America Market Share, By End User, 2022 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By End User – 2022 to 2032
Figure 22: North America Market Attractiveness Index, By End User – 2022 to 2032
Figure 23: North America Market Share, By Treatment Type, 2022 & 2032
Figure 24: North America Market Y-o-Y Growth Projections, By Treatment Type – 2022 to 2032
Figure 25: North America Market Attractiveness Index, By Treatment Type – 2022 to 2032
Figure 26: North America Market Share, By Country, 2022 & 2032
Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 28: North America Market Attractiveness Index, By Country – 2022 to 2032
Figure 29: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 30: Latin America Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 31: Latin America Market Share, By Indication, 2022 & 2032
Figure 32: Latin America Market Y-o-Y Growth Projections, By Indication – 2022 to 2032
Figure 33: Latin America Market Attractiveness Index, By Indication – 2022 to 2032
Figure 34: Latin America Market Share, By End User, 2022 & 2032
Figure 35: Latin America Market Y-o-Y Growth Projections, By End User – 2022 to 2032
Figure 36: Latin America Market Attractiveness Index, By End User – 2022 to 2032
Figure 37: Latin America Market Share, By Treatment Type, 2022 & 2032
Figure 38: Latin America Market Y-o-Y Growth Projections, By Treatment Type – 2022 to 2032
Figure 39: Latin America Market Attractiveness Index, By Treatment Type – 2022 to 2032
Figure 40: Latin America Market Share, By Country, 2022 & 2032
Figure 41: Latin America Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 42: Latin America Market Attractiveness Index, By Country – 2022 to 2032
Figure 43: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 44: Europe Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 45: Europe Market Share, By Indication, 2022 & 2032
Figure 46: Europe Market Y-o-Y Growth Projections, By Indication – 2022 to 2032
Figure 47: Europe Market Attractiveness Index, By Indication – 2022 to 2032
Figure 48: Europe Market Share, By End User, 2022 & 2032
Figure 49: Europe Market Y-o-Y Growth Projections, By End User – 2022 to 2032
Figure 50: Europe Market Attractiveness Index, By End User – 2022 to 2032
Figure 51: Europe Market Share, By Treatment Type, 2022 & 2032
Figure 52: Europe Market Y-o-Y Growth Projections, By Treatment Type – 2022 to 2032
Figure 53: Europe Market Attractiveness Index, By Treatment Type – 2022 to 2032
Figure 54: Europe Market Share, By Country, 2022 & 2032
Figure 55: Europe Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 56: Europe Market Attractiveness Index, By Country – 2022 to 2032
Figure 57: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 58: MEA Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 59: MEA Market Share, By Indication, 2022 & 2032
Figure 60: MEA Market Y-o-Y Growth Projections, By Indication – 2022 to 2032
Figure 61: MEA Market Attractiveness Index, By Indication – 2022 to 2032
Figure 62: MEA Market Share, By End User, 2022 & 2032
Figure 63: MEA Market Y-o-Y Growth Projections, By End User – 2022 to 2032
Figure 64: MEA Market Attractiveness Index, By End User – 2022 to 2032
Figure 65: MEA Market Share, By Treatment Type, 2022 & 2032
Figure 66: MEA Market Y-o-Y Growth Projections, By Treatment Type – 2022 to 2032
Figure 67: MEA Market Attractiveness Index, By Treatment Type – 2022 to 2032
Figure 68: MEA Market Share, By Country, 2022 & 2032
Figure 69: MEA Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 70: MEA Market Attractiveness Index, By Country – 2022 to 2032
Figure 71: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 72: Asia Pacific Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 73: Asia Pacific Market Share, By Indication, 2022 & 2032
Figure 74: Asia Pacific Market Y-o-Y Growth Projections, By Indication – 2022 to 2032
Figure 75: Asia Pacific Market Attractiveness Index, By Indication – 2022 to 2032
Figure 76: Asia Pacific Market Share, By End User, 2022 & 2032
Figure 77: Asia Pacific Market Y-o-Y Growth Projections, By End User – 2022 to 2032
Figure 78: Asia Pacific Market Attractiveness Index, By End User – 2022 to 2032
Figure 79: Asia Pacific Market Share, By Treatment Type, 2022 & 2032
Figure 80: Asia Pacific Market Y-o-Y Growth Projections, By Treatment Type – 2022 to 2032
Figure 81: Asia Pacific Market Attractiveness Index, By Treatment Type – 2022 to 2032
Figure 82: Asia Pacific Market Share, By Country, 2022 & 2032
Figure 83: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 84: Asia Pacific Market Attractiveness Index, By Country – 2022 to 2032
Figure 85: US Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 86: US Market Share, By Indication, 2021
Figure 87: US Market Share, By End User, 2021
Figure 88: US Market Share, By Treatment Type, 2021
Figure 89: Canada Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 90: Canada Market Share, By Indication, 2021
Figure 91: Canada Market Share, By End User, 2021
Figure 92: Canada Market Share, By Treatment Type, 2021
Figure 93: Brazil Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 94: Brazil Market Share, By Indication, 2021
Figure 95: Brazil Market Share, By End User, 2021
Figure 96: Brazil Market Share, By Treatment Type, 2021
Figure 97: Mexico Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 98: Mexico Market Share, By Indication, 2021
Figure 99: Mexico Market Share, By End User, 2021
Figure 100: Mexico Market Share, By Treatment Type, 2021
Figure 101: Germany Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 102: Germany Market Share, By Indication, 2021
Figure 103: Germany Market Share, By End User, 2021
Figure 104: Germany Market Share, By Treatment Type, 2021
Figure 105: U.K. Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 106: U.K. Market Share, By Indication, 2021
Figure 107: U.K. Market Share, By End User, 2021
Figure 108: U.K. Market Share, By Treatment Type, 2021
Figure 109: France Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 110: France Market Share, By Indication, 2021
Figure 111: France Market Share, By End User, 2021
Figure 112: France Market Share, By Treatment Type, 2021
Figure 113: Italy Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 114: Italy Market Share, By Indication, 2021
Figure 115: Italy Market Share, By End User, 2021
Figure 116: Italy Market Share, By Treatment Type, 2021
Figure 117: BENELUX Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 118: BENELUX Market Share, By Indication, 2021
Figure 119: BENELUX Market Share, By End User, 2021
Figure 120: BENELUX Market Share, By Treatment Type, 2021
Figure 121: Nordic Countries Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 122: Nordic Countries Market Share, By Indication, 2021
Figure 123: Nordic Countries Market Share, By End User, 2021
Figure 124: Nordic Countries Market Share, By Treatment Type, 2021
Figure 125: China Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 126: China Market Share, By Indication, 2021
Figure 127: China Market Share, By End User, 2021
Figure 128: China Market Share, By Treatment Type, 2021
Figure 129: Japan Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 130: Japan Market Share, By Indication, 2021
Figure 131: Japan Market Share, By End User, 2021
Figure 132: Japan Market Share, By Treatment Type, 2021
Figure 133: South Korea Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 134: South Korea Market Share, By Indication, 2021
Figure 135: South Korea Market Share, By End User, 2021
Figure 136: South Korea Market Share, By Treatment Type, 2021
Figure 137: GCC Countries Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 138: GCC Countries Market Share, By Indication, 2021
Figure 139: GCC Countries Market Share, By End User, 2021
Figure 140: GCC Countries Market Share, By Treatment Type, 2021
Figure 141: South Africa Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 142: South Africa Market Share, By Indication, 2021
Figure 143: South Africa Market Share, By End User, 2021
Figure 144: South Africa Market Share, By Treatment Type, 2021
Figure 145: Turkey Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 146: Turkey Market Share, By Indication, 2021
Figure 147: Turkey Market Share, By End User, 2021
Figure 148: Turkey Market Share, By Treatment Type, 2021
- FAQs -
What was the documented market worth for sacroiliac joint fusion in 2021?
As of 2021, the sacroiliac joint fusion market was valued at US$ 540 Mn, as per Fact.MR
At what value will sacroiliac joint fusion reach as of 2022?
According to Fact.MR, demand for sacroiliac joint fusion is expected to reach US$ 620 Mn by 2022
What is the expected growth rate for the sacroiliac joint fusion industry until 2032?
By 2032, the sacroiliac joint fusion industry is expected to flourish at a CAGR of 20.2%
What is the anticipated market value for sacroiliac joint fusion market in 2032?
By 2032, Fact.MR foresees the sacroiliac joint fusion market to be valued at US$ 3,900 Mn
At what percentage did sacroiliac joint fusion market evolve during the past 6 years?
From 2015 to 2021, sacroiliac joint fusion demand surged at a CAGR of 18%
What is the growth outlook for sacroiliac joint fusion across North America?
In North America, sacroiliac joint fusion surgeries will account for 42% of the global market demand in 2022
How opportunistic is will the market for sacroiliac joint fusion be across Asia Pacific?
Across the Asia Pacific, demand for sacroiliac joint fusion is expected to rise at a CAGR of 17%
By indication, which segment is likely to emerge dominant across the forecast period?
Degenerative sacroiliitis is expected to be the prominent indication segment, accumulating 39% market revenue in 2022
Which treatment category will account for maximum revenue share in 2022?
Sacroiliac joint fusion surgeries are expected to account for 40% market revenue in 2022
Sacroiliac Joint Fusion Market